[1] 金嬴. 福岛核灾害的人权问题及其历史根源探析[J]. 日本学刊, 2024(5): 35-61+161. JIN Ying. An analysis of the human rights issues and historical roots of the Fukushima nuclear disaster[J]. Japanese Studies, 2024(5): 35-61+161. [2] United Nations Scientific Committee on the Effects of Atomic Radiation. Sources, effects and risks of ionizing radiation: united nations scientific committee on the effects of atomic radiation: UNSCEAR 2020/2021 Report to the General Assembly with Scientific Annexes: Volume II Scientific Annex B[R]. New York: United Nations, 2021. [3] Ministry of Health, Labour and Welfare. Responses and actions taken by the Ministry of Health, Labour and Welfare of Japan on radiation protection at works relating to the accident at TEPCO's Fukushima Daiichi Nuclear Power Plant 7th edition (fiscal year of 2019)[R]. Tokyo: Office for Radiation Protection of Workers, 2020. [4] Ministry of Health, Labour and Welfare. Responses and actions taken by the Ministry of Health, Labour and Welfare of Japan on radiation protection at works relating to the accident at TEPCO's Fukushima Daiichi Nuclear Power Plant 8th edition (fiscal year of 2020)[R]. Tokyo: Office for Radiation Protection of Workers, 2021. [5] Ministry of Health, Labour and Welfare. Responses and actions taken by the Ministry of Health, Labour and Welfare of Japan on radiation protection at works relating to the accident at TEPCO's Fukushima Daiichi Nuclear Power Plant 9th edition (fiscal year of 2021)[R]. Tokyo: Office for Radiation Protection of Workers, 2021. [6] United Nations Scientific Committee on the Effects of Atomic Radiation. Sources, effects and risks of ionizing radiation united nations scientific committee on the effects of atomic radiation:UNSCEAR 2013 Report to the General Assembly with Scientific Annexes: Volume I scientific Annex A[R]. New York: United Nations, 2014. [7] Editorial Committee for the Paper on Decontamination. Decontamination projects for radioactive contamination discharged by Tokyo Electric Power Company Fukushima Daiichi Nuclear Power Station accident[R]. Tokyo: Ministry of the Environment, 2020. [8] Sakumi A, Miyagawa R, Tamari Y, et al. External effective radiation dose to workers in the restricted area of the Fukushima Daiichi Nuclear Power Plant during the third year after the great east Japan earthquake[J]. Journal of Radiation Research, 2016, 57(2): 178-181. [9] Matsuda N, Yoshida K, Nakashima K, et al. Initial activities of a radiation emergency medical assistance team to Fukushima from Nagasaki[J]. Radiation Measurements, 2013, 55: 22-25. [10] TEPCO. Evaluation of the exposure dose of workers engaged in radiation work at the Fukushima Daiichi Nuclear Power Station[R]. Tokyo, 2015. [11] Kunishima, N, Tani K, Kurihara O, et al. Numerical simulation based on individual voxel phantoms for a sophisticated evaluation of internal doses mainly from 131 I in highly exposed workers involved in the TEPCO Fukushima Daiichi NPP accident[J]. Health Physics, 2019, 116(5): 647-656. [12] ICRP. Limits for intakes of radionuclides by workers[R]. Oxford: Pergamon Press, 1982. [13] Yokoyama, S, Hamada N, Hayashida T, et al. Current situations and discussions in Japan in relation to the new occupational equivalent dose limit for the lens of the eye[J]. Journal of Radiological Protection: Official Journal of the Society for Radiological Protection, 2017, 37(3): 659-683. [14] 付熙明, 袁龙, 孙全富. 日本福岛事故10周年剂量与健康效应评估[J]. 中国辐射卫生, 2021, 30(6): 732-738. FU Ximing, YUAN Long, SUN Quanfu. An assessment of the radiation dose and health effects of the Fukushima nuclear accident in Japan over the past 10 years[J]. Chinese Journal of Radiological Health, 2021, 30(6): 732-738. [15] Omori Y, Hosoda M, Takahashi F, et al. Japanese population dose from natural radiation[J]. Journal of Radiological Protection: Official Journal of the Society for Radiological Protection, 2020, 40(3): R99-R140. [16] Imaizumi M, Ohishi W, Nakashima E, et al. Thyroid dysfunction and autoimmune thyroid diseases among atomic bomb survivors exposed in childhood[J]. The Journal of Clinical Endocrinology and Metabolism, 2017, 102(7): 2516-2524. [17] ICRP. ICRP statement on tissue reactions/early and late effects of radiation in normal tissues and organs-threshold doses for tissue reactions in a radiation protection context[R]. Amsterdam: Elsevier, 2012. [18] Shimura, H, Sobue T, Takahashi H, et al. Findings of thyroid ultrasound examination within 3 years after the Fukushima Nuclear Power Plant accident: the Fukushima health management survey[J]. The Journal of Clinical Endocrinology and Metabolism, 2018, 103(3): 861-869. [19] FHMS. Summary results of thyroid screening (1st to 4th rounds)[C]//39th Prefectural Oversight Committee Meeting for Fukushima Health Management Survey. Fukushima: Fukushima Medical University, 2020. [20] Shimura H, Yokoya S, Suzuki S, et al. Confounding factors and biases involved in regional differences in the detection rate of thyroid cancer in the second-round thyroid ultrasound examination: the Fukushima health management survey[J]. Journal of Radiation Research, 2023, 64(5): 761-768. [21] Tsuda, T, Tokinobu A, Yamamoto E, et al. Thyroid cancer detection by ultrasound among residents ages 18 years and younger in Fukushima, Japan: 2011 to 2014[J]. Epidemiology, 2016, 27(3): 316-322. [22] Kato T. Re: associations between childhood thyroid cancer and external radiation dose after the Fukushima Daiichi Nuclear Power Plant accident[J]. Epidemiology, 2019, 30(2): e9-e11. [23] Mitsutake N, Fukushima T, Matsuse M, et al. BRAFV600E mutation is highly prevalent in thyroid carcinomas in the young population in Fukushima: A different oncogenic profile from Chernobyl[J]. Scientific reports, 2015, 5: 16976. [24] Hamatani K, Eguchi H, Ito R, et al. RET/PTC rearrangements preferentially occurred in papillary thyroid cancer among atomic bomb survivors exposed to high radiation dose[J]. Cancer Research, 2008, 68(17): 7176-7182. [25] Klugbauer S, Lengfelder E, Demidchik E P, et al. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident[J]. Oncogene, 1995, 11(12): 2459-2467. [26] Nikiforov Y E. Radiation-induced thyroid cancer: what we have learned from Chernobyl[J]. Endocrine Pathology, 2006, 17(4): 307-317. [27] Fenton C L, Lukes Y, Nicholson D, et al. The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults[J]. The Journal of Clinical Endocrinology and Metabolism, 2000, 85(3): 1170-1175. [28] Powell N, Jeremiah S, Morishita M, et al. Frequency of BRAF T1796A mutation in papillary thyroid carcinoma relates to age of patient at diagnosis and not to radiation exposure[J]. The Journal of Pathology, 2005, 205(5): 558-564. [29] Tronko M D, Saenko V A, Shpak V M, et al. Age distribution of childhood thyroid cancer patients in Ukraine after Chernobyl and in Fukushima after the TEPCO-Fukushima Daiichi NPP accident[J]. Thyroid, 2014, 24(10): 1547-1548. [30] Lubin J H, Adams M J, Shore R, et al. Thyroid cancer following childhood low-dose radiation exposure: A pooled analysis of nine cohorts[J]. The Journal of Clinical Endocrinology and Metabolism, 2017, 102(7): 2575-2583. [31] Fukushima Prefecture Radiation Monitoring Office. Results of γ-ray nuclide analysis of airborne dust during emergency monitoring[R]. Fukushima: Fukushima Prefecture Radiation Monitoring Office, 2016. [32] Nagataki S, Takamura N. A review of the Fukushima nuclear reactor accident: Radiation effects on the thyroid and strategies for prevention[J]. Current Opinion in Endocrinology, Diabetes, and Obesity, 2014, 21(5): 384-393. [33] Jargin S V. Chernobyl-related thyroid cancer[J]. European Journal of Epidemiology, 2018, 33(4): 429-431. [34] Etherington G, Zhang Wei, Harrison J, et al. Worker doses and potential health effects resulting from the accident at the Fukushima Nuclear Power Plant in 2011[J]. International Journal of Radiation Biology, 2014, 90(11): 1088-1094. [35] LIU Mengjie, Matsunaga H, Orita M, et al. Risk perception of genetic effects and mental health among residents of Kawauchi village, 10 years after the Fukushima Daiichi Nuclear Power Plant accident[J]. Journal of Radiation Research, 2022, 63(2): 261-263. [36] Shimura T, Yamaguchi I, Terada H, et al. Radiation occupational health interventions offered to radiation workers in response to the complex catastrophic disaster at the Fukushima Daiichi Nuclear Power Plant[J]. Journal of Radiation Research, 2015, 56(3): 413-421. [37] MHLW. Report of clinical study subcommittee of epidemiological study on health effects among radiation workers supported by industrial disease clinical research grants[R]. Ministry of Health, Labour and Welfare, 2020. [38] 刘长安, 李小娟, 李峰生, 等. 福岛第一核电站应急工作人员的职业照射管理和健康监护[J]. 中国工业医学杂志, 2014, 27(2): 144-149. LIU Changan, LI Xiaojuan, LI Fengsheng, et al. Occupational radiation management and health surveillance for emergency personnel at Fukushima Daiichi Nuclear Power Plant[J]. Chinese Journal of Industrial Medicine, 2014, 27(2): 144-149. [39] Parker C, Nilsson S, Heinrich D, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer[J]. The New England Journal of Medicine, 2013, 369(3): 213-223. [40] Lassmann M, Nosske D. Dosimetry of 223Ra-chloride: Dose to normal organs and tissues[J]. European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40(2): 207-212. [41] 陈惠芳, 袁龙, 雷翠萍. 严重核事故应急救援人员的心理危机干预[J]. 中国辐射卫生, 2022, 31(3): 314-319. CHEN Huifang, YUAN Long, LEI Cuiping. Psychological crisis intervention for emergency rescue workers during major nuclear power plant accident[J]. Chinese Journal of Radiological Health, 2022, 31(3): 314-319. |